Abstract
A major action of adenosine is the induction of profound behavioral inactivity. 6-(4-Nitrobenzyl)-thioinosine (NBI) and 6-(2-hydroxy-5-nitrobenzyl)-thioguanosine (NBG) have been shown to inhibit adenosine uptake. To investigate the possible synergism between exogenous ligand and reuptake inhibition, mice were treated with NBI or NBG + adenosine. NBI and NBG potentiated the effects of adenosine at doses which did not in themselves induce behavioral inactivity. These behavioral results support the proposed role of NBI and NBG as adenosine uptake site blockers which increase synaptic concentrations of adenosine and postsynaptic responses to adenosine in vivo.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 169-174 |
| Number of pages | 6 |
| Journal | Neuroscience Letters |
| Volume | 36 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 11 1983 |
| Externally published | Yes |
Keywords
- adenosine
- reuptake inhibition
- sedation
ASJC Scopus subject areas
- Neuroscience(all)
Fingerprint Dive into the research topics of 'Adenosine uptake inhibitors potentiate the sedative effects of adenosine'. Together they form a unique fingerprint.
Cite this
Crawley, J., Patel, J., & Marangos, P. J. (1983). Adenosine uptake inhibitors potentiate the sedative effects of adenosine. Neuroscience Letters, 36(2), 169-174. https://doi.org/10.1016/0304-3940(83)90260-4